Press Releases
Recession Resister has launched a smart new utility bill auditing tool called Bill Saver aimed at helping career transitioners enhance their budget sustainability.
—
Recession Resister has created Bill Saver in response to the rising costs of utilities and monthly bills for individuals and families across America. With this smart auditing solution, they will show career transitioners and other people in a moment of financial flux... (continue reading...)
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITYRule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Name of exempt principal trader:HSBC Bank Plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeWood Group (John) plc(c) Name of the party to the offer with which... (continue reading...)Hardware wallet cases allow cryptocurrency collectors to keep their devices safe from damage. The Crypto Merchant moves to make such gear readily available, announcing an expansion to its accessory selection.
—
The Crypto Merchant has expanded its product array to provide cryptocurrency enthusiasts with access to a wider line of protective cases. Its newly added accessories are compatible with wallets by leading brands,... (continue reading...)
Shanghai, China--(Newsfile Corp. - June 14, 2024) - NETA L announces It has reached over 30,000 orders within just 35 days since launch in April. This impressive sales figure is a standout achievement among Chinese automotive brands.
In the electrification era, China's new energy vehicles (NEVs) are at the forefront of technological innovation and industry upgrading. Among these, NETA stands out as a prominent player in the global market. In 2018, NETA launched its... (continue reading...)
LUND, SE / ACCESSWIRE / June 14, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; NasdaqStockholm:CANTA) today reported progress in the ongoing phase 1 clinical trial of the CAN10 antibody. Seven dose groups have now been concluded without any safety concerns. Furthermore, additional receptor occupancy studies confirm that CAN10 saturates its target molecule, IL1RAP, on immune cells from the study participants. The study follows timelines with the next dose group... (continue reading...)
More Press Releases
View Older Stories-
Research from Hellotickets Reveals the Best and Worst Travel Destinations in Europe for Hayfever Sufferers
-
BabyBonk (BABYBONK) Is Now Available for Tranding on LBank Exchange
-
The Happiness Warrior Eric North shares Twenty Ways to Make Optimism a Superpower
-
Allegro Launches New Project Management Service Line to Be Led by Mike Davies
-
Hisense TV Ranked No. 2 Globally in Q1 2024
-
IL House Speaker Emanuel "Chris" Welch Brings Back Pride Month Celebration June 27th
-
Study: Texas Housing Markets Moderating Among Sunbelt States
-
Team Nick Coates Awards Are Presented to Police Officers For Their Work To Apprehend Impaired Drivers
-
Speech and More Launches Comprehensive Speech Therapy Services Across Australia
-
1st Quarter Results
-
Notification of major holding in Kindred Group plc
-
Notification of executives and related parties’ transactions with Nilfisk shares
-
Custom Mylar Bags: 4 Printing Techniques to Elevate Your Packaging
-
Form 8.5 (EPT/RI) - Trinity Exploration & Production Plc
-
RESULT OF RIKSBANK AUCTIONS GOVERNMENT BONDS
-
Launch of Mukkpet Ebikes - Family Rides for More Exercise and Less Screen Time
-
IQ Medical Ventures rebrands as IQ Women's Health to pioneer innovations in women's Health
-
Form 8.3 - Hargreaves Lansdown Plc
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
Form 8.3 - International Distributions Services Plc
-
Form 8.5 (EPT/RI) - FireAngel Safety Technology Group Plc
-
Yiren Digital to Report First Quarter 2024 Financial Results on June 21, 2024
-
Hilbert Group Subsidiary COIN360.COM Announces Major Overhaul and Strategic Partnership with 4+Ventures
-
Introducing ZW3D 2025: Embark on a Seamless Journey from Design to Manufacturing
-
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
-
HSBC Bank plc: Post Stabilisation Notice
-
Early Signals by WOO X: BTC Faces Downward Trend While TON Ecosystem Reaches New Highs with Surging Market Interest
-
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
-
Zefiro Publishes “Letter from the CEO” Following its Inaugural Earnings Report
-
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the 2024 Annual European Hematology Association (EHA) Congress
-
Flash News: OKX Announces Exclusive Minting of Slerf NFTs on its Marketplace
-
Dividend payment ex-date of Aktsiaselts Tallinna Vesi
-
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress
-
Protagonist Reports Updated Long Term Results from Rusfertide Phase 2 REVIVE Study at the EHA2024 Congress Showing Durable Hematocrit Control
-
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma
-
Immune-Onc Therapeutics to Present Additional Positive Interim Data from IO-202 Phase 1b Expansion Cohort in Patients with Chronic Myelomonocytic Leukemia (CMML) at 2024 European Hematology Associatio
-
Brickken is selected to participate in the European Blockchain Regulatory Sandbox
-
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease
-
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (E
-
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimilar), at the European Hematology Association (EHA) Congress 2024
-
INTENDED NON-EXECUTIVE DIRECTOR APPOINTMENT
-
Passionpreneur Publishing announces that Uriel Jaroslawski has started the journey of becoming a published author.
-
Expats soak up Duanwu fun in Shandong
-
Filipinos Amazed By Visayan Island's White Sand Beaches - Not Commercialized - Zero Light Pollution - GREAT STARGAZING
-
Renault Group: Implementation of the share buyback programme
-
The Safavi Impact Institute Sponsors NASA's Space Center Houston's pilot education program in Austria
-
RAMSAY SANTE :Cosem medical centers takeover
-
Southern Energy Corp. Announces Amendments to Outstanding Convertible Debentures
-
Bradda Head Lithium Ltd Announces Drilling Results for Basin Lithium-in-Clay Project